Aarti Drugs Ltd. is a high-risk pharmaceutical company based in India that specializes in providing active pharmaceutical ingredients (APIs) in various therapeutic categories. They offer a wide range of products including anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamin APIs such as Aceclofenac, Celecoxib, and Moxifloxacin. The company primarily generates revenue from operations within India. With a Risk Rating Score of 34.9, Aarti Drugs Ltd. is focused on environment, sustainability, and governance (ESG) practices.